修改虚弱指数在经过最少侵入性大动脉置换的八重生患者中的预后作用
Beatrice Bacchi1, Francesco Cabrucci2, Dario Petrone1
1Cardiac Surgery Unit, Department of Experimental and Clinical Medicine, University of Florence, 50121 Firenze, Italy.
Journal of clinical medicine
|July 29, 2025
概括
修改后的虚弱指数 (mFI) 准确地预测了接受轻微侵入性大动脉置换 (AVR) 的老年患者的结果. 较高的MFI分数表明死亡率和并发症风险增加,有助于外科决定.
科学领域:
- 心脏病学 心脏病学
- 老年人手术是一门老年手术.
- 健康 结果 研究 研究 结果
背景情况:
- 虚弱是影响老年患者手术风险的关键因素.
- 八十岁的阿动脉置换 (AVR) 需要精确的风险分层.
- 最少侵入性AVR提供了好处,但需要仔细选择患者.
研究的目的:
- 评估修改后的脆弱指数 (mFI) 的预后能力在接受微创性AVR的八十岁人群中.
- 改善风险分层,指导这一脆弱群体的外科决策.
- 为了将MFI与AVR后的早期和长期结果相关联.
主要方法:
- 对67名年龄≥80岁的患者进行了回顾性分析,这些患者接受了孤立的最小侵入性AVR.
- 使用标准化临床变量进行mFI的手术前计算.
- 使用ROC曲线,卡普兰-梅尔和考克斯回归评估30天死亡率,外科并发症和长期存活率.
主要成果:
- 多元金融机构在死亡率和并发症方面都表现出很强的预后准确性.
- 一个mFI>0.455预测了30天死亡率,具有高灵敏度和特异性 (AUC = 0.888).
- 一个mFI>0.273预测了术后并发症 (AUC = 0.818),更高的得分预测了长期死亡率.
结论:
- 该mFI是一个简单的,可重复的工具,用于预测在接受微创AVR的非常老年患者的结果.
- 将脆弱性评估整合到手术前的评估中,可以提高患者的选择.
- 优先考虑生理状态而不是时间年龄可能会优化手术结果.
更多相关视频
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.8K
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
8.0K
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
40
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
40
01:19Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
01:27Mitral Valve Prolapse I: Introduction
43
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
43
01:27Mitral Stenosis IV: Nursing Management
47
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
47
01:25Aortic Regurgitation III: Medical Management
44
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
44
01:26Mitral Stenosis III: Medical Management
23
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
23